订阅小程序
旧版功能

Safety and Efficacy of Subcutaneous Iscalimab (CFZ533) in Two Distinct Populations of Patients with Sjögren's Disease (TWINSS): Week 24 Results of a Randomised, Double-Blind, Placebo-Controlled, Phase 2b Dose-Ranging Study

Benjamin A. Fisher,Xavier Mariette,Athena S. Papas,Thomas Grader-Beck,Hendrika Bootsma,Wan-Fai Ng,Paul Van Daele,Stephanie Finzel, Sergio Elgueta,Josef Hermann,Sara McCoy,Arthur Bookman,Monika Sopala,Wen-Lin Luo, Cornelia Scheurer,Wolfgang Hueber

ARTHRITIS & RHEUMATOLOGY（2023）

引用 5|浏览6
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要